Active substances
Hydrocortisone + Neomycin
- SFDA 3
- US FDA 6
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| COLIRCUSI H.C WITH NEOM | 15, 3.5 mg/ml | Eye drops · Ocular use | 1 Dropper Container | SAR 8.95 | Generic · Prescription | ALCON CUSI | Withdrawn by MAH · Not Marketed |
| NEO-CORTEF E-E OINT 1.5% | 1.5, 0.5 % | Ear/eye ointment · Topical | 1 Tube | SAR 13.15 | NCE · Prescription | PHARMACIA UPJOHN | Withdrawn by MAH · Not Marketed |
| NEOMYCIN-HYDROCORTISOINE OINT | 1 % | Ointment · Topical | 1 Tube | SAR 5.00 | Generic · Prescription | LABORATORIES AVENTIS (USIPHER) | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NEO-CORT-DOME | 1%;EQ 3.5MG BASE/GM; 0.5%;EQ 3.5MG BASE/GM | cream · topical | BAYER PHARMS | Discontinued | 19 Oct 1964 |
| NEO-CORTEF | 0.5%;EQ 3.5MG BASE/GM; 1%;EQ 3.5MG BASE/GM; 2.5%;EQ 3.5MG BASE/GM | ointment · topical | PHARMACIA AND UPJOHN | Discontinued | 18 May 1965 |
| COR-OTICIN | 1.5%;EQ 3.5MG BASE/ML | suspension/drops · ophthalmic | EPIC PHARMA LLC | Discontinued | 26 Oct 1968 |
| NEO-CORTEF | 0.5%;EQ 3.5MG BASE/GM; 1.5%;EQ 3.5MG BASE/GM | ointment · ophthalmic | PHARMACIA AND UPJOHN | Discontinued | |
| NEO-CORTEF | 1.5%;EQ 3.5MG BASE/ML; 0.5%;EQ 3.5MG BASE/ML | suspension/drops · ophthalmic | PHARMACIA AND UPJOHN | Discontinued | |
| NEO-CORTEF | 1%;EQ 3.5MG BASE/GM; 2.5%;EQ 3.5MG BASE/GM | cream · topical | PHARMACIA AND UPJOHN | Discontinued |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.